Chihiro Omori

Nara Medical University

Papers

1

Total Citations

4

H-Index

1

About

Dr. Chihiro Omori is a distinguished urologic surgeon and researcher whose work centers on optimizing surgical outcomes for patients with localized prostate cancer, with a particular focus on the role of pelvic lymph node dissection during robot-assisted radical prostatectomy. His landmark 2022 study, which has garnered 4 citations, rigorously compared the clinical significance of limited versus extended pelvic lymph node dissection using a retrospective, propensity score matching analysis. This work provided critical insights into the diagnostic and therapeutic benefits of these approaches, specifically evaluating pN1 rates and biochemical recurrence. Dr. Omori’s contributions help refine surgical decision-making, balancing the oncologic necessity of lymph node staging against the potential morbidity of more extensive dissection. His research is instrumental for urologists seeking to personalize surgical strategies, ensuring that patients receive the most effective, evidence-based care. By clarifying the trade-offs between limited and extended dissection, Dr. Omori continues to shape best practices in robotic prostate cancer surgery, directly impacting patient outcomes and advancing the field of urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Clinical significance of limited and extended pelvic lymph node dissection during robot‐assisted radical prostatectomy for patients with localized prostate cancer: A retrospective, propensity score matching analysis
4 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Nara Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago